Virofob

Virofob is an oral antiviral medication containing tenofovir disoproxil, used to manage chronic hepatitis B and HIV. It belongs to the nucleotide reverse transcriptase inhibitor class. This EU-manufactured treatment supports viral load reduction.

Tenofovir disoproxil, the active ingredient in Virofob, is primarily used to treat chronic hepatitis B virus (HBV) infections and as part of combination therapy for HIV-1. It works by inhibiting viral replication. Patients with detectable HBV DNA or elevated liver enzymes may benefit from this medication. Always consult a healthcare provider for suitability.

Virofob may help reduce viral activity in the body, supporting liver health in hepatitis B cases. Some users report improved energy levels and reduced symptoms over time. Individual responses vary, and effects depend on consistent use. Regular monitoring is recommended during treatment.

Store Virofob at room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your doctor about any kidney issues before starting this medication. Do not alter your dose without medical guidance.

Virofob may interact with other drugs that affect kidney function or compete for renal excretion. Combining it with nephrotoxic agents (e.g., NSAIDs) requires caution. Alcohol may increase side effects; discuss use with a healthcare provider. Always review your full medication list with a clinician.